Performance Evaluation of Self-Curing Concrete Incorporating Palm Oil Fuel Ash
International Journal of Creative and Open Research in Engineering and Management · 25.05.2026 · 02 (05) · 1-4
DOI: 10.55041/ijcope.v2i5.756 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Creative and Open Research in Engineering and Management, online erschienen am 25.05.2026. Verfasst von Dr. P. Nirmal Dr. P. Nirmal und 1 weiteren Autor:innen.
Abstract (Originalsprache)
This study investigates the performance of self-curing concrete incorporating Polyethylene Glycol (PEG-400) as an internal curing agent and Palm Oil Fuel Ash (POFA) as a partial replacement for cement. The fresh, mechanical, and durability properties of the concrete were evaluated using standard tests. The results showed that PEG-400 improved internal moisture retention and hydration efficiency, while POFA enhanced long-term strength and durability through pozzolanic reaction. The combined use of PEG-400 and POFA produced sustainable and water-efficient concrete. Keywords— Self-curing concrete, Palm Oil Fuel Ash, PEG-400, Sustainable concrete, Internal curing.
Zitieren
APA
Nirmal, D. P. N. D. P., & Ravi, S. R. S. (2026). Performance Evaluation of Self-Curing Concrete Incorporating Palm Oil Fuel Ash. International Journal of Creative and Open Research in Engineering and Management, 02(05), 1-4. https://doi.org/10.55041/ijcope.v2i5.756
Vancouver
Nirmal DPNDP, Ravi SRS. Performance Evaluation of Self-Curing Concrete Incorporating Palm Oil Fuel Ash. International Journal of Creative and Open Research in Engineering and Management. 2026;02(05):1-4. doi:10.55041/ijcope.v2i5.756
BibTeX
@article{Nirmal2026,
author = {Nirmal, Dr. P. Nirmal Dr. P. and Ravi, Sujithaa Ravi Sujithaa},
title = {Performance Evaluation of Self-Curing Concrete Incorporating Palm Oil Fuel Ash},
journal = {International Journal of Creative and Open Research in Engineering and Management},
year = {2026},
volume = {02},
number = {05},
pages = {1--4},
doi = {10.55041/ijcope.v2i5.756}
}
EUVIMED